| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/16/2009 | US7547443 Skin care topical ointment |
| 06/16/2009 | US7547433 Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| 06/16/2009 | CA2591758C Applicator for the delivery of topical formulation into mucosal cavities |
| 06/16/2009 | CA2476934C Stabilized tnfr-fc composition comprising arginine |
| 06/16/2009 | CA2415154C Modified release formulations of selective serotonin re-uptake inhibitors |
| 06/16/2009 | CA2396180C Stable aqueous deoxyfructosazine solution |
| 06/16/2009 | CA2382540C High viscosity liquid composition for the delivery of substances |
| 06/16/2009 | CA2361936C Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 06/16/2009 | CA2357744C Potassium salt of (s)-omeprazole |
| 06/16/2009 | CA2340898C Compositions and methods for treating intracellular infections |
| 06/16/2009 | CA2334810C Method and device for delivery of therapeutic agents in conjunction with isotope seed placement |
| 06/16/2009 | CA2330500C Pharmaceutical compositions capable of being gelled |
| 06/16/2009 | CA2304975C Stabilized preparations for use in metered dose inhalers |
| 06/16/2009 | CA2243201C Process for producing sustained-release preparation |
| 06/16/2009 | CA2192786C Cyclopeptolide inhibitors of adhesion molecules |
| 06/11/2009 | WO2009073814A2 Oligo-ethylene glycol-based polymer compositions and methods of use |
| 06/11/2009 | WO2009073791A1 Coating suitable for medicament contact |
| 06/11/2009 | WO2009073711A1 Improved formulations and methods for lyophilization and lyophilates provided thereby |
| 06/11/2009 | WO2009073658A1 Self solidifying bioerodible barrier implant |
| 06/11/2009 | WO2009073630A2 Methods and compositons for enhancing the viability of microneedle pores |
| 06/11/2009 | WO2009073612A2 Homeopathic remedies for use before and after aesthetic injectable and surgical procedures to minimize swelling and bruising |
| 06/11/2009 | WO2009073541A2 Thermoresponsive arginine-based hydrogels as biologic carriers |
| 06/11/2009 | WO2009073517A2 Intravesical compositions with valrubicin for the treatment of bladder cancer |
| 06/11/2009 | WO2009073508A2 Polysaccharide gel compositions and methods for sustained delivery of drugs |
| 06/11/2009 | WO2009073437A1 Polysaccharide gel formulation |
| 06/11/2009 | WO2009073337A1 Powder cosmetic composition |
| 06/11/2009 | WO2009073216A1 Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer |
| 06/11/2009 | WO2009073012A1 Method for applying a polymer coating to an internal surface of a container |
| 06/11/2009 | WO2009072953A1 Process and arrangement for producing particles utilizing subcritical fluids |
| 06/11/2009 | WO2009072950A1 Method and arrangement for the production of particles |
| 06/11/2009 | WO2009072889A1 Bifidobacterium for dust mite allergy |
| 06/11/2009 | WO2009072674A1 Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same |
| 06/11/2009 | WO2009072657A1 Nanofunctional silica particles and manufacturing method thereof |
| 06/11/2009 | WO2009072572A1 Edible film |
| 06/11/2009 | WO2009072334A1 Core particle for pharmaceutical preparation |
| 06/11/2009 | WO2009072146A1 Biocompatible and biodegradable biopolymer matrix |
| 06/11/2009 | WO2009072079A2 Polymeric drug carrier for image-guided delivery |
| 06/11/2009 | WO2009071959A2 Composition containing itraconazole |
| 06/11/2009 | WO2009071954A1 Effervescent tablets and effervescent granules containing carnitine tartrate |
| 06/11/2009 | WO2009071850A2 Nanoparticles of therapeutic agents having low water solubility |
| 06/11/2009 | WO2009071794A1 Method of manufacturing silica-coated metal nanoparticles |
| 06/11/2009 | WO2009071599A1 Immunotherapeutic method for increasing groundnut tolerance in a subject |
| 06/11/2009 | WO2009071326A2 Transdermal therapeutic system having a content of a modulator for nicotinic acetylcholine receptors (nachr) |
| 06/11/2009 | WO2009071308A1 Pharmaceutical containing a hormone combination having a contraceptive effect and an insulin sensitizer |
| 06/11/2009 | WO2009071219A2 Oral dispersable tablet |
| 06/11/2009 | WO2009070979A1 An oral cavity rapid release preparation and its preparation method |
| 06/11/2009 | WO2009070974A1 Therapeutic composition containing amlodipine nicotinate and statins |
| 06/11/2009 | WO2009070973A1 Therapeutic composition containing amlodipine nicotinate and sartans |
| 06/11/2009 | WO2009070957A1 Inhibitor of the interaction between blys and ngr and use thereof |
| 06/11/2009 | WO2009070921A1 Antimelancholic medicine prepared with jujube camp materials |
| 06/11/2009 | WO2009070917A1 An oral pharmaceutical composition for treating barythymia |
| 06/11/2009 | WO2009055742A3 Delivery of active agents |
| 06/11/2009 | WO2009055740A3 Method of preventing adverse effects by glp-1 |
| 06/11/2009 | WO2009053937A3 Nano-lipid-based carriers for targeted delivery of viral vectors and process for its production |
| 06/11/2009 | WO2009049820A3 Amorphous formulation |
| 06/11/2009 | WO2009044056A3 Device for the oral administration of active principles |
| 06/11/2009 | WO2009037183A3 Cosmetic and/or pharmaceutical preparation containing nucleic acid for the induction of antimicrobial peptides in epithelia |
| 06/11/2009 | WO2009031890A3 A carrier particle for use in bio-applications |
| 06/11/2009 | WO2009019294A9 Bupropion hydrobromide and therapeutic applications |
| 06/11/2009 | WO2009012908A3 Medicament for transdermal use on animals |
| 06/11/2009 | WO2008147373A3 Methods and compositions for reducing body weight using an estrogen fatty ester in an oil |
| 06/11/2009 | WO2008122994A3 Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof |
| 06/11/2009 | WO2008068778A3 Extended release pharmaceutical composition of pramipexole |
| 06/11/2009 | WO2007067206A3 Obesity treatment systems |
| 06/11/2009 | WO2006125166A3 Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| 06/11/2009 | WO2003028622A3 Method of delivering drugs to a tissue using drug-coated medical devices |
| 06/11/2009 | WO2003011214A3 Novel methods and formulations for administration of active agents |
| 06/11/2009 | WO2002058484A3 Kolla 2-desiccated avian sternal cartilage powder |
| 06/11/2009 | US20090149839 Treatment techniques using ingestible device |
| 06/11/2009 | US20090149831 Polymeric Microspheres for Treatment of Obesity |
| 06/11/2009 | US20090149543 Solid pharmaceutical compositions comprising lumiracoxib |
| 06/11/2009 | US20090149502 a mixture of 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one and an adrenergic agonist selected from the group consisting of albuterol, terbutaline, fenoterol, formoterol and salmeterol, used for the treatment of allergies, skin and respiratory system disorders |
| 06/11/2009 | US20090149473 Topical antifungal composition |
| 06/11/2009 | US20090149453 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 06/11/2009 | US20090149391 Novel antimicrobial bolisin peptides |
| 06/11/2009 | US20090149388 Dried blood factor composition comprising trehalose |
| 06/11/2009 | US20090148829 Methods For Rapid Identification Of Pathogens In Humans And Animals |
| 06/11/2009 | US20090148535 Method for treating cancer using interference rna |
| 06/11/2009 | US20090148534 Process for producing water-soluble hyaluronic acid modification |
| 06/11/2009 | US20090148533 Ion binding compositions |
| 06/11/2009 | US20090148532 Preparation of controlled release skeletal muscle relaxant dosage forms |
| 06/11/2009 | US20090148531 Rate-controlled particles |
| 06/11/2009 | US20090148530 Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin |
| 06/11/2009 | US20090148529 Hydrogel Suspension and Manufacturing Process Thereof |
| 06/11/2009 | US20090148528 Material that progressively liberates an active liquid substance by evaporation, and mosquito repellent bracelet incorporating such a material |
| 06/11/2009 | US20090148527 Intraocular formulation |
| 06/11/2009 | US20090148526 Salts of potassium atp channel openers and uses thereof |
| 06/11/2009 | US20090148525 Pharmaceutical formulations of potassium atp channel openers and uses thereof |
| 06/11/2009 | US20090148524 Method of producing solid preparation disintegrating in the oral cavity |
| 06/11/2009 | US20090148523 System and process for providing at least one opening in dosage forms |
| 06/11/2009 | US20090148522 Heated roller compaction process for making pharmaceutical compositions |
| 06/11/2009 | US20090148521 Solid oral form of a medicinal preparation and a method for the production thereof |
| 06/11/2009 | US20090148520 Tablet |
| 06/11/2009 | US20090148519 Pulsed-release preparation having improved disintegration properties in vivo |
| 06/11/2009 | US20090148518 Pharmaceutical Formulations |
| 06/11/2009 | US20090148517 Melt-extrusion multiparticulates |
| 06/11/2009 | US20090148516 Treated feed supplement capsule for ruminants |
| 06/11/2009 | US20090148515 Two-piece metal capsule for accommodating pharmaceutical preparations for powder inhalers |
| 06/11/2009 | US20090148514 Multipart capsule for staged release of one or more pharmaceutical compositions |
| 06/11/2009 | US20090148513 Compositions and methods for crystallizing antibodies |